Xinyu Wu Selected Research

Xinyu Wu Research Topics

Disease

31	Neoplasms (Cancer) 12/2023 - 07/2011
10	Inflammation (Inflammations) 10/2023 - 01/2021
8	Osteosarcoma (Osteogenic Sarcoma) 01/2016 - 10/2012
7	Prostatic Neoplasms (Prostate Cancer) 01/2022 - 01/2013
7	Ankylosing Spondylitis 01/2021 - 01/2015
7	Rheumatoid Arthritis 01/2020 - 01/2012
6	Breast Neoplasms (Breast Cancer) 09/2023 - 07/2011
4	Periodontitis 04/2024 - 01/2022
4	Pain (Aches) 01/2024 - 01/2020
4	Hypoxia (Hypoxemia) 01/2024 - 06/2016
4	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2022 - 01/2022
3	Neoplasm Metastasis (Metastasis) 09/2023 - 08/2013
3	Infections 01/2022 - 01/2019
3	Systemic Lupus Erythematosus (Libman-Sacks Disease) 07/2020 - 11/2015
3	Carcinoma (Carcinomatosis) 01/2020 - 01/2011
3	Carcinogenesis 01/2016 - 01/2011
2	Necrosis 01/2024 - 12/2023
2	Myocardial Infarction 04/2023 - 05/2017
2	Pneumonia (Pneumonitis) 01/2023 - 12/2020
2	Asthma (Bronchial Asthma) 01/2023 - 01/2023
2	Hematologic Neoplasms (Hematological Malignancy) 12/2022 - 02/2020
2	Parkinson Disease (Parkinson's Disease) 10/2022 - 07/2020
2	Cardiomyopathies (Cardiomyopathy) 01/2022 - 01/2022
2	Sepsis (Septicemia) 01/2022 - 02/2020
2	Postoperative Pain 06/2021 - 11/2011
2	Gout 02/2021 - 01/2020
2	Experimental Arthritis 01/2020 - 12/2019
2	Disease Progression 01/2018 - 08/2013
2	Ovarian Neoplasms (Ovarian Cancer) 01/2016 - 01/2011
1	Intervertebral Disc Degeneration 05/2024
1	Hypertension (High Blood Pressure) 05/2024
1	Dysbiosis 04/2024
1	Cholangiocarcinoma 03/2024
1	Mitochondrial Diseases (Mitochondrial Disease) 02/2024

Drug/Important Bio-Agent (IBA)

14	Proteins (Proteins, Gene)FDA Link 11/2023 - 01/2012
9	Biomarkers (Surrogate Marker)IBA 09/2023 - 01/2013
7	Ether (Diethyl Ether)IBA 01/2016 - 10/2012
6	Hormones (Hormone)IBA 09/2023 - 01/2011
6	LigandsIBA 01/2022 - 02/2013
6	Androgen Receptors (Androgen Receptor)IBA 06/2016 - 01/2011
5	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2024 - 10/2012
5	MicroRNAs (MicroRNA)IBA 01/2022 - 01/2013
5	Small Interfering RNA (siRNA)IBA 11/2015 - 10/2012
4	Caspase 3 (Caspase-3)IBA 01/2024 - 11/2015
4	Transcription Factors (Transcription Factor)IBA 12/2023 - 01/2013
4	Immunoglobulins (Immunoglobulin)IBA 02/2021 - 11/2015
4	AndrogensIBA 06/2016 - 01/2011
4	Sincalide FDA Link 01/2016 - 01/2013
4	Potassium Channels (Potassium Channel)IBA 01/2016 - 03/2013
3	InterleukinsIBA 01/2024 - 04/2014
3	Fatty Acids (Saturated Fatty Acids)IBA 09/2023 - 01/2014
3	p38 Mitogen-Activated Protein KinasesIBA 06/2023 - 03/2013
3	Estrogen ReceptorsIBA 12/2022 - 07/2011
3	Messenger RNA (mRNA)IBA 01/2022 - 01/2013
3	Co-Repressor ProteinsIBA 06/2016 - 02/2014
3	SteroidsIBA 02/2014 - 01/2013
2	Sirolimus (Rapamycin)FDA Link 02/2024 - 01/2024
2	Caspase 9IBA 01/2024 - 01/2023
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2024 - 02/2013
2	Indicators and Reagents (Reagents)IBA 01/2024 - 12/2022
2	Reactive Oxygen Species (Oxygen Radicals)IBA 12/2023 - 01/2022
2	LipidsIBA 12/2023 - 01/2014
2	DNA (Deoxyribonucleic Acid)IBA 11/2023 - 11/2020
2	Dental Implants (Dental Implant)IBA 10/2023 - 01/2022
2	IntegrinsIBA 09/2023 - 09/2022
2	Coenzyme A (CoA)IBA 08/2023 - 01/2014
2	avermectinIBA 06/2023 - 10/2022
2	difenoconazoleIBA 04/2023 - 01/2023
2	CytokinesIBA 01/2023 - 04/2014
2	Oxygen (Dioxygen)IBA 01/2023 - 01/2022
2	AntigensIBA 12/2022 - 01/2022
2	ErbB Receptors (EGF Receptor)IBA 12/2022 - 11/2019
2	rac1 GTP-Binding ProteinIBA 10/2022 - 07/2020
2	Competitive Endogenous RNAIBA 01/2022 - 01/2022
2	Immune Checkpoint InhibitorsIBA 01/2022 - 08/2017
2	HydrogelsIBA 01/2022 - 01/2021
2	Lapatinib (GW572016)FDA Link 01/2022 - 01/2013
2	human ERBB2 proteinIBA 01/2022 - 01/2013
2	EnzymesIBA 01/2022 - 01/2014
2	Therapeutic UsesIBA 06/2021 - 12/2019
2	Uric Acid (Urate)IBA 02/2021 - 01/2020
2	Adalimumab (Humira)FDA Link 01/2021 - 01/2020
2	C-Reactive ProteinIBA 01/2020 - 01/2020
2	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 06/2016 - 02/2014
1	Becaplermin (PDGF-BB)FDA Link 05/2024
1	Antihypertensive Agents (Antihypertensives)IBA 05/2024
1	Neurokinin-1 Receptor AntagonistsIBA 03/2024
1	Aprepitant (Emend)FDA Link 03/2024
1	Doxorubicin (Adriamycin)FDA LinkGeneric 02/2024
1	Free Radical ScavengersIBA 02/2024
1	ferrostatin-1IBA 02/2024
1	Dacarbazine (DIC)FDA LinkGeneric 02/2024
1	MitoTEMPOIBA 02/2024
1	Superoxides (Superoxide)IBA 02/2024

Therapy/Procedure

19	Therapeutics 05/2024 - 02/2013
8	Drug Therapy (Chemotherapy) 05/2024 - 04/2018
6	Immunotherapy 12/2022 - 06/2018
4	Chinese Traditional Medicine (Traditional Chinese Medicine) 05/2024 - 06/2021
2	Moxibustion 05/2024 - 06/2021
2	Oral Hygiene (Dental Hygiene) 04/2024 - 12/2020